Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Med (New York, N.Y.)|December 14, 2024
Transformative or transitional? Deciphering the role of NIAGARA in shaping future practiceDaniele Raggi, Robert A HuddartCurrent Opinion in Urology|August 13, 2002
Adjuvant chemotherapy for high-risk low-stage germ-cell tumoursAlan Horwich, Robert A HuddartAdvances in Urology|May 30, 2018
Adjuvant Therapy for Stage IB Germ Cell Tumors: One versus Two Cycles of BEPRobert A Huddart, Alison M ReidExpert Review of Anticancer Therapy|March 11, 2005
Recent advances in the treatment of testicular cancerRobert A Huddart, Alison J BirtleEuropean Urology Focus|July 21, 2017
Positron Emission Tomography Scanning for Recurrent Bladder CancerJames M Wilson, Robert A HuddartInternational Journal of Molecular Sciences|August 31, 2018
Circulating Tumour DNA in Muscle-Invasive Bladder CancerMelissa P Tan, Gerhardt Attard, Robert A HuddartNature Reviews. Urology|November 3, 2016
The present and future of serum diagnostic tests for testicular germ cell tumoursMatthew J Murray, Robert A Huddart, Nicholas ColemanCurrent Drug Discovery Technologies|June 13, 2009
Novel targeted radiosensitisers in cancer treatmentShane H Zaidi, Robert A Huddart, Kevin J HarringtonExpert Review of Anticancer Therapy|February 6, 2009
Reducing treatment toxicities in the management of good prognosis testicular germ cell tumorsDuncan C Gilbert, Nicholas J Van As, Robert A HuddartNature Reviews. Urology|June 15, 2016
The genomic landscape of testicular germ cell tumours: from susceptibility to treatmentKevin Litchfield, Max Levy, Robert A Huddart, et al.Pageof 10